Schroder Investment Management Group Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Schroder Investment Management Group increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 37.8% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,994,739 shares of the real estate investment trust’s stock after purchasing an additional 547,491 shares during the quarter. Schroder Investment Management Group’s holdings in Sabra Healthcare REIT were worth $37,062,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of SBRA. Private Advisor Group LLC boosted its stake in Sabra Healthcare REIT by 2.1% during the third quarter. Private Advisor Group LLC now owns 37,193 shares of the real estate investment trust’s stock worth $693,000 after buying an additional 750 shares during the period. Diversify Advisory Services LLC raised its stake in shares of Sabra Healthcare REIT by 7.0% in the third quarter. Diversify Advisory Services LLC now owns 81,088 shares of the real estate investment trust’s stock valued at $1,451,000 after acquiring an additional 5,277 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter worth about $386,000. Natixis Advisors LLC lifted its holdings in shares of Sabra Healthcare REIT by 2.2% in the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after acquiring an additional 598 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Sabra Healthcare REIT by 61.7% during the 3rd quarter. First Trust Advisors LP now owns 595,612 shares of the real estate investment trust’s stock worth $11,102,000 after purchasing an additional 227,229 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Down 0.8%

Shares of SBRA opened at $20.65 on Thursday. The firm has a market capitalization of $5.21 billion, a price-to-earnings ratio of 32.27, a PEG ratio of 1.67 and a beta of 0.64. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. Sabra Healthcare REIT, Inc. has a 1-year low of $15.75 and a 1-year high of $21.07. The company has a 50-day moving average of $19.58 and a 200 day moving average of $18.99.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.Sabra Healthcare REIT’s revenue was up 16.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is 187.50%.

Analysts Set New Price Targets

SBRA has been the topic of several analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Thursday, January 22nd. Scotiabank raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “sector perform” rating in a research note on Monday, March 2nd. Cantor Fitzgerald boosted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Tuesday, February 17th. Wells Fargo & Company upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Finally, Citizens Jmp increased their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $21.80.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.